Denisov A A, Torskiĭ S P, Nikolaeva O G, Volozhantseva I Ia
Biokhimiia. 1995 Sep;60(9):1403-10.
The biosynthesis of recombinant human lymphotoxin produced by E. coli SG20050/pLT21 cells and deprived of 21 amino acid residues has been studied. It has been shown that the bulk of the recombinant protein in E. coli cells is in the soluble form and predominantly localized in the cytoplasm. The maximal synthesis of soluble recombinant lymphotoxin is achieved during 24-hour cultivation of producing strain cells at 32 degrees C. A procedure for isolation and purification of the recombinant protein from E. coli cells has been developed. The purification is accomplished by gel-filtration on Sephadex G-150, ion-exchange chromatography on DEAE-Sephadex and CM-Sephadex, resulting in 97-fold purification and a 62% yield. The specific activity of the protein is about 1-10(8) U per mg of protein. Some physico-chemical properties of the recombinant protein have been studied.
对大肠杆菌SG20050/pLT21细胞产生的、缺失21个氨基酸残基的重组人淋巴毒素的生物合成进行了研究。结果表明,大肠杆菌细胞中的大部分重组蛋白呈可溶形式,主要定位于细胞质中。在32℃下对生产菌株细胞进行24小时培养时,可溶重组淋巴毒素的合成达到最大值。已开发出从大肠杆菌细胞中分离和纯化重组蛋白的方法。通过在Sephadex G - 150上进行凝胶过滤、在DEAE - Sephadex和CM - Sephadex上进行离子交换色谱进行纯化,纯化倍数达97倍,产率为62%。该蛋白的比活性约为每毫克蛋白1 - 10(8) U。已对重组蛋白的一些物理化学性质进行了研究。